Format

Send to

Choose Destination
Eur J Clin Pharmacol. 2013 Feb;69(2):269-77. doi: 10.1007/s00228-012-1331-5. Epub 2012 Jun 17.

Safety of ginger use in pregnancy: results from a large population-based cohort study.

Author information

1
Department of Public Health and Primary Health Care and Centre of Pharmacy, University of Bergen, P.O. Box 7804, 5020 Bergen, Norway. kristine.heitmann@isf.uib.no

Abstract

PURPOSE:

The objective of the study was to examine the safety of ginger use during pregnancy on congenital malformations and selected pregnancy outcomes.

METHODS:

The Norwegian Mother and Child Cohort study, a large population-based cohort, provided the data used in this study. Our study population consisted of 68,522 women. Data on ginger use and socio-demographic factors were retrieved from three self-administered questionnaires completed by the women during weeks 17 and 30 of the pregnancy and when their child was 6 months old. Data on pregnancy outcomes were provided by the Medical Birth Registry of Norway.

RESULTS:

Among the 68,522 women in the study, 1,020 (1.5 %) women reported using ginger during pregnancy. The use of ginger during pregnancy was not associated with any increased risk of congenital malformations. No increased risk for stillbirth/perinatal death, preterm birth, low birth weight, or low Apgar score was detected for the women exposed to ginger during pregnancy compared to women who had not been exposed.

CONCLUSION:

Use of ginger during pregnancy does not seem to increase the risk of congenital malformations, stillbirth/perinatal death, preterm birth, low birth weight, or low Apgar score. This finding is clinically important for health care professionals giving advice to pregnant women with NPV.

PMID:
22706624
DOI:
10.1007/s00228-012-1331-5
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center